AcornMed

BiotechnologySeries BBeijing, Chinaacornmed.com

Latest round

Series B

Last raised

Dec 2022

Total raised

$43M

Investors

8

About AcornMed

Based in Beijing, China, and established in 2018, AcornMed is a biotechnology company that focuses on cancer gene testing services and medical equipment and has test R&D centers in Beijing and Tianjin. It owns approximately 100 invention patents and software copyrights. Moreover, it established cooperation with MGI Tech. Co., Huawei Cloud, Twist Bioscience, AZN, and Roche. More than 80% of the technical personnel have masters or doctoral degrees. AcornMed provides 40 gene test products for solid tumors and hematological tumors including 20 gene test products that received CE certification. The gene test products for solid tumors include lung cancer, rectal cancer, and urological tumors. It also established gene data databases, which include over 100,000 cancer patients' genomic data.

Who invested in AcornMed

8 investors across 2 rounds

See all investors in AcornMed

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 27, 2022

    Amount

    $29M

    Investors

    Locked

  2. Series A

    Jan 1, 2020

    Amount

    $14M

    Investors

    Locked

Questions about AcornMed

Who invested in AcornMed?

AcornMed has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AcornMed raised?

AcornMed has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did AcornMed last raise money?

AcornMed's most recent round on record is a Series B, in Dec 2022.

What does AcornMed do?

Based in Beijing, China, and established in 2018, AcornMed is a biotechnology company that focuses on cancer gene testing services and medical equipment and has test R&D centers in Beijing and Tianjin.

Where is AcornMed headquartered?

AcornMed is headquartered in Beijing, China.

Which VCs invest in companies like AcornMed?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at AcornMed's stage. Their profiles are linked below.

Raising like AcornMed? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.